Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Kari B. Wisinski · SciRah

Researcher profile · Semantic Scholar

Kari B. Wisinski

Share profile

Kari B. Wisinski — researcher profile on SciRah

h-index: 34
Works: 161
Citations: 6,503

Most-cited papers

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
M. Daly, T. Pal, Michael P. Berry, S. Buys +30 more
2021The Journal of the National Comprehensive Cancer Network863 citations Open access
Semantic Scholar
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
W. Gradishar, M. Moran, J. Abraham, R. Aft +33 more
2022The Journal of the National Comprehensive Cancer Network797 citations
Semantic Scholar
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
W. Gradishar, Meena S. Moran, Jame Abraham, V. Abramson +35 more
2024The Journal of the National Comprehensive Cancer Network649 citations
Semantic Scholar
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
W. Gradishar, M. Moran, J. Abraham, V. Abramson +33 more
2023The Journal of the National Comprehensive Cancer Network420 citations Open access
Semantic Scholar
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
M. Daly, R. Pilarski, M. Yurgelun, Michael P. Berry +29 more
2020The Journal of the National Comprehensive Cancer Network413 citations Open access
Semantic Scholar
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
W. Gradishar, M. Moran, J. Abraham, R. Aft +34 more
2021The Journal of the National Comprehensive Cancer Network266 citations Open access
Semantic Scholar
Tumor cell-driven extracellular matrix remodeling drives haptotaxis during metastatic progression
Madeleine J. Oudin, O. Jonas, Tatsiana Kosciuk, Liliane C. Broye +15 more
2016Cancer Discovery181 citations Open access
Semantic Scholar
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial
K. Kalinsky, M. Accordino, C. Chiuzan, P. Mundi +19 more
2023Journal of Clinical Oncology156 citations
Semantic Scholar
PARP Inhibition in BRCA-Mutant Breast Cancer
A. Turk, Kari B. Wisinski
2018Cancer143 citations Open access
Semantic Scholar
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis.
Lu Wang, Zi-Bo Zhao, M. Meyer, Sandeep Saha +9 more
2016Cancer Cell120 citations Open access
Semantic Scholar
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
J. Ayuso, Regan Truttschel, Max M. Gong, Mouhita Humayun +9 more
2018Oncoimmunology114 citations Open access
Semantic Scholar
The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients.
Karla Esbona, Yan-Yao Yi, Sandeep Saha, Meng-Gang Yu +8 more
2018American Journal of Pathology113 citations Open access
Semantic Scholar
Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel
Christina M. Scribano, Jun Wan, Karla Esbona, John B. Tucker +17 more
2021Science Translational Medicine106 citations Open access
Semantic Scholar
NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021
M. Daly, T. Pal, Michael P. Berry, S. Buys +30 more
202088 citations
Semantic Scholar
Breast Cancer, Version 3.2022
W. Gradishar, M. Moran, J. Abraham, R. Aft +33 more
202281 citations
Semantic Scholar
Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients.
J. Ayuso, M. Virumbrales-Muñoz, Patrick H. McMinn, Shujah Rehman +6 more
2019Lab on a Chip79 citations Open access
Semantic Scholar
Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations
J. Ayuso, A. Gillette, Karina M. Lugo-Cintrón, S. Acevedo-Acevedo +7 more
2018EBioMedicine78 citations Open access
Semantic Scholar
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy
Jason I. Griffiths, Jin-Feng Chen, Patrick A. Cosgrove, A. O'Dea +14 more
2021Nature Cancer77 citations Open access
Semantic Scholar
Paclitaxel induces micronucleation and activates pro-inflammatory cGAS-STING signaling in triple-negative breast cancer
Yang Hu, Baraa K. Manasrah, S. McGregor, Robert F. Lera +13 more
2021Molecular Cancer Therapeutics69 citations Open access
Semantic Scholar
Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial).
Qamar J. Khan, A. O'Dea, A. Bardia, K. Kalinsky +16 more
202058 citations
Semantic Scholar
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X. Ma, V. Suman, M. Goetz, D. Northfelt +30 more
2017Clinical Cancer Research57 citations Open access
Semantic Scholar
BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
M. Elezaby, B. Lees, K. Maturen, L. Barroilhet +4 more
2019Radiology48 citations
Semantic Scholar
Phase 1 study of an AKT-inhibitor (MK-2206) combined with lapatinib in adult solid tumors followed by dose-expansion in advanced HER2+ breast cancer
Kari B. Wisinski, Amye J. Tevaarwerk, M. Burkard, M. Rampurwala +5 more
2016Clinical Cancer Research48 citations Open access
Semantic Scholar
Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells
J. Ayuso, Ross A Vitek, Adam D. Swick, M. Skala +4 more
2019Scientific Reports38 citations Open access
Semantic Scholar
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
A. Choudhury, C. Higano, J. de Bono, N. Cook +22 more
2022Clinical Cancer Research36 citations Open access
Semantic Scholar
Targeting Estrogen Receptor Beta in a Phase II Study of High Dose Estradiol in Metastatic Triple Negative Breast Cancer: A Wisconsin Oncology Network Study
Kari B. Wisinski, Wei Xu, Amye J. Tevaarwerk, Sandeep Saha +8 more
2016Clinical Breast Cancer28 citations Open access
Semantic Scholar
Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2
Kari B. Wisinski, Yael Flamand, M. Wilson, J. Luke +20 more
2023JCO Precision Oncology21 citations Open access
Semantic Scholar
Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast Cancer
Shelby A. Fertal, Johanna E Poterala, S. Ponik, Kari B. Wisinski
2022Cancers19 citations Open access
Semantic Scholar
Anti-estrogen therapy increases plasticity and cancer stemness of prolactin-induced ERα+ mammary carcinomas
Michael P. Shea, K. O'Leary, S. Fakhraldeen, V. Goffin +4 more
2018Cancer Research19 citations Open access
Semantic Scholar
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B.
P. Bedard, Shu-Li Li, Kari B. Wisinski, E. Yang +17 more
2022JCO Precision Oncology17 citations Open access
Semantic Scholar
Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: a Wisconsin Oncology Network study
Amye J. Tevaarwerk, K. Kwekkeboom, K. Buhr, Alexandra Dennee +11 more
2020Cancer17 citations Open access
Semantic Scholar
BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity
Eui-Jun Kim, Peng Liu, Sheng-Jie Zhang, K. Donahue +13 more
2021Nucleic Acids Research16 citations Open access
Semantic Scholar
Accuracy and thoroughness of treatment summaries provided as part of survivorship care plans prepared by two cancer centers
Amye J. Tevaarwerk, W. Hocking, Jamie Zeal, Mindy Gribble +6 more
2017Journal of Oncology Practice15 citations Open access
Semantic Scholar
Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer.
S. Kamaraju, A. Fowler, E. Weil, Kari B. Wisinski +8 more
2021Endocrinology14 citations Open access
Semantic Scholar
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
T. Leal, M. Sharifi, N. Chan, R. Wesolowski +13 more
2022Cancer Medicine13 citations Open access
Semantic Scholar
A first in human phase I study of AZD8186, a potent and selective inhibitor of PI3K in patients with advanced solid tumours as monotherapy and in combination with the dual mTORC1/2 inhibitor vistusertib (AZD2014) or abiraterone acetate.
A. Hansen, G. Shapiro, K. Do, Rajiv Kumar +16 more
201711 citations
Semantic Scholar
Abstract CT139: NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activating mutations
P. Bedard, Shu-Li Li, Kari B. Wisinski, E. Yang +16 more
2019Clinical Trials9 citations
Semantic Scholar
Abstract OT1-02-01: Phase I trial of bicalutamide and ribociclib in androgen receptor-positive triple negative breast cancer
M. Sharifi, Kari B. Wisinski, M. Burkard, Amye J. Tevaarwerk +6 more
2019Ongoing Clinical Trials9 citations
Semantic Scholar
Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?
M. Sharifi, R. O'Regan, Kari B. Wisinski
2023Clinical Breast Cancer8 citations
Semantic Scholar
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers
S. Phadke, Kathy D. Miller, A. Shah, O. Danciu +4 more
2025Breast Cancer Research and Treatment7 citations
Semantic Scholar
Trastuzumab and Pertuzumab in Patients with non-Breast/Gastroesophageal HER2-amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol J
R. Connolly, V. Wang, David M. Hyman, P. Grivas +18 more
2024Clinical Cancer Research7 citations Open access
Semantic Scholar
Concurrent Radiation and Modern Systemic Therapies for Breast Cancer: An Ever-Expanding Frontier.
J. Witt, Kari B. Wisinski, B. Anderson
2021Clinical Breast Cancer7 citations
Semantic Scholar
AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).
J. de Bono, A. Hansen, Ananya Choudhury, N. Cook +15 more
2018Annals of Oncology7 citations Open access
Semantic Scholar
Assessment of Adherence and Relative Dose Intensity with Oral Chemotherapy in Oncology Clinical Trials at an Academic Medical Center
Jeff A Engle, A. Traynor, Toby C. Campbell, Kari B. Wisinski +4 more
2017Journal of Oncology Pharmacy Practice7 citations Open access
Semantic Scholar
A phase I study of veliparib (Vel) in combination with oxaliplatin (Ox) and capecitabine (Cap) in advanced solid tumors.
A. Turk, D. Deming, S. Lubner, D. Mulkerin +5 more
20185 citations
Semantic Scholar
Genomic Testing in the Management of Early-Stage Breast Cancer
S. Ehsani, Kari B. Wisinski
2017Journal of Clinical Outcomes Management5 citations
Semantic Scholar
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8+ T Cells in Breast Cancer
Philip Emmerich, Tonela Qyli, Katherine A. Johnson, Somak Chaudhuri +11 more
2025Cancers4 citations Open access
Semantic Scholar
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.
S. Kamaraju, Amy M. Fowler, S. Tarima, L. Chaudhary +20 more
2024Clinical Breast Cancer4 citations
Semantic Scholar
Abstract P2-02-02: Phase I trial of the safety and immunogenicity of a tri-antigen vaccine targeting HER2, IGFBP-2, and IGF-IR in patients with non-metastatic breast cancer
S. Stanton, Kari B. Wisinski, W. Gwin, A. Coveler +12 more
2023Cancer Research4 citations
Semantic Scholar
VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments.
Philip Emmerich, K. Matkowskyj, S. McGregor, Sean G. Kraus +13 more
20204 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Burkard×10
Invite
M. Burkard — researcher profile on SciRah
R. O'Regan×9
Invite
R. O'Regan — researcher profile on SciRah
Amye J. Tevaarwerk×9
Invite
Amye J. Tevaarwerk — researcher profile on SciRah
R. Aft×6
Invite
R. Aft — researcher profile on SciRah

E. Stringer-Reasor

×6

Invite

E. Stringer-Reasor — researcher profile on SciRah

W. Gradishar×5

Invite

W. Gradishar — researcher profile on SciRah

Invite

M. Goetz — researcher profile on SciRah

R. Jankowitz×5

Invite

R. Jankowitz — researcher profile on SciRah

Sara H. Javid×5

Invite

Sara H. Javid — researcher profile on SciRah

Invite

H. Rugo — researcher profile on SciRah

Invite

H. Soliman — researcher profile on SciRah

Invite

M. Telli — researcher profile on SciRah